Powell Mark R
Risk Anal. 2014 Jan;34(1):93-100. doi: 10.1111/risa.12054. Epub 2013 Apr 24.
Much of the literature regarding food safety sampling plans implicitly assumes that all lots entering commerce are tested. In practice, however, only a fraction of lots may be tested due to a budget constraint. In such a case, there is a tradeoff between the number of lots tested and the number of samples per lot. To illustrate this tradeoff, a simple model is presented in which the optimal number of samples per lot depends on the prevalence of sample units that do not conform to microbiological specifications and the relative costs of sampling a lot and of drawing and testing a sample unit from a lot. The assumed objective is to maximize the number of nonconforming lots that are rejected subject to a food safety sampling budget constraint. If the ratio of the cost per lot to the cost per sample unit is substantial, the optimal number of samples per lot increases as prevalence decreases. However, if the ratio of the cost per lot to the cost per sample unit is sufficiently small, the optimal number of samples per lot reduces to one (i.e., simple random sampling), regardless of prevalence. In practice, the cost per sample unit may be large relative to the cost per lot due to the expense of laboratory testing and other factors. Designing effective compliance assurance measures depends on economic, legal, and other factors in addition to microbiology and statistics.
许多关于食品安全抽样计划的文献都隐含地假定所有进入商业流通的批次都经过检测。然而在实际操作中,由于预算限制,可能只有一小部分批次会接受检测。在这种情况下,检测的批次数量和每个批次的样本数量之间存在权衡。为了说明这种权衡,我们提出一个简单模型,其中每个批次的最佳样本数量取决于不符合微生物规格的样本单元的流行率以及对一个批次进行抽样和从一个批次中抽取并检测一个样本单元的相对成本。假定的目标是在食品安全抽样预算限制下,使被拒收的不合格批次数量最大化。如果每个批次的成本与每个样本单元的成本之比很大,那么每个批次的最佳样本数量会随着流行率的降低而增加。然而,如果每个批次的成本与每个样本单元的成本之比足够小,那么每个批次的最佳样本数量会减少到一个(即简单随机抽样),而与流行率无关。在实际中,由于实验室检测费用和其他因素,每个样本单元的成本相对于每个批次的成本可能会很高。除了微生物学和统计学之外,设计有效的合规保证措施还取决于经济、法律和其他因素。